Facebook Twitter RSS Feed
 - breaking the bank, money

Use of IMRT to treat prostate cancer, which carries a reimbursement rate approximately 50 percent higher than conformal radiotherapy, skyrocketed from zero in 2000 to 82.1 percent in 2009 among postprostatectomy patients. Despite the swift uptake, IMRT may not provide morbidity benefits among these patients, according to a study published online May 20 in JAMA Internal Medicine.

 - Computer Globe

Although teleradiology services offer a number of benefits to healthcare providers and their patients, the American College of Radiology’s (ACR’s) Task Force on Teleradiology Practice stated that the traditional practice model of on-site, local radiology groups may better serve most communities.

 - cancer

Indeterminate renal masses detected on CT colonography (CTC) warrant follow-up as they have a one-in-five chance of malignancy, according a review of research of extracolonic findings on CTC published in the June issue of Academic Radiology.

 - Alzheimer's Disease

Developers of the first FDA-approved imaging agent for the diagnosis of Alzheimer’s, Eli Lily and Company and Avid Pharmaceuticals, held a conference call May 16 for stakeholders and members of the media to discuss the Center for Medicare & Medicaid Service's (CMS) upcoming draft decision regarding coverage for Amyvid and other beta-amyloid type diagnostic agents.

 - Middle-aged woman

The U.S. Preventive Task Services (USPSTF) recommendations that women ages 50-74 years undergo biennial screening mammography and women ages 40-49 years make an individual decision regarding screening had little impact on screening mammography use, according to a study published online May 15 in Journal of General Internal Medicine.